Source:http://linkedlifedata.com/resource/pubmed/id/19909396
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2011-3-25
|
pubmed:abstractText |
In the treatment of acute ischemic stroke, intravenous (IV) recombinant tissue plasminogen (rt-PA) and intraarterial (IA) interventions are often combined. However, the optimal dose of IV rt-PA preceding endovascular treatment has not been established.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
1552-6569
|
pubmed:author | |
pubmed:copyrightInfo |
Copyright © 2009 by the American Society of Neuroimaging.
|
pubmed:issnType |
Electronic
|
pubmed:volume |
21
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
113-20
|
pubmed:meshHeading |
pubmed-meshheading:19909396-Fibrinolytic Agents,
pubmed-meshheading:19909396-Humans,
pubmed-meshheading:19909396-Infusions, Intravenous,
pubmed-meshheading:19909396-Injections, Intravenous,
pubmed-meshheading:19909396-Recombinant Proteins,
pubmed-meshheading:19909396-Stroke,
pubmed-meshheading:19909396-Tissue Plasminogen Activator,
pubmed-meshheading:19909396-Treatment Outcome
|
pubmed:year |
2011
|
pubmed:articleTitle |
Comparison of partial (.6 mg/kg) versus full-dose (.9 mg/kg) intravenous recombinant tissue plasminogen activator followed by endovascular treatment for acute ischemic stroke: a meta-analysis.
|
pubmed:affiliation |
Zeenat Qureshi Stroke Research Center, Department of Neurology, University of Minnesota, Minneapolis, Minnesota 55455, USA. alg1971@gmail.com
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Meta-Analysis
|